We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Sphere Medical

Sphere Medical develops medical monitoring and diagnostic equipment, including the CE-marked Proxima platform for mea... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Blood Gas Analyzer Supports Rapid Critical Point-of-Care Measurements

By LabMedica International staff writers
Posted on 02 Oct 2014
Print article
Image: The new Proxima in-line patient-dedicated arterial blood gas analyzer incorporates the Proxima Sensor (in foreground) and a dedicated bedside monitor (Photo courtesy of Sphere Medical).
Image: The new Proxima in-line patient-dedicated arterial blood gas analyzer incorporates the Proxima Sensor (in foreground) and a dedicated bedside monitor (Photo courtesy of Sphere Medical).
Image: The miniaturized Proxima Sensor is integrated into a patient’s arterial line to be used for directly monitoring blood gases and electrolytes, per 72 hour period as many times as required (Photo courtesy of Sphere Medical).
Image: The miniaturized Proxima Sensor is integrated into a patient’s arterial line to be used for directly monitoring blood gases and electrolytes, per 72 hour period as many times as required (Photo courtesy of Sphere Medical).
Image: The miniaturized Proxima Sensor is integrated into a patient’s arterial line to be used for directly monitoring blood gases and electrolytes (Photo courtesy of Sphere Medical).
Image: The miniaturized Proxima Sensor is integrated into a patient’s arterial line to be used for directly monitoring blood gases and electrolytes (Photo courtesy of Sphere Medical).
A novel miniature, patient dedicated in-line blood gas analyzer improves critical care by providing near real-time measurements at laboratory analyzer accuracy.

Sphere Medical (Cambridge, UK), innovator in critical care monitoring and diagnostics equipment, has launched its cutting-edge analyzer, Proxima, at the Association of Anesthetists of Great Britain and Ireland Annual Congress (AAGBI) 2014 (September 17-19, 2014, Harrogate, UK). The Proxima miniaturized blood gas analyzer uniquely delivers rapid, frequent results at patient bedside to enable fast response, proactive critical care—closer control of therapeutic response leading to improved patient outcome, as well as to reduced overall cost of care.

CE-marked and designed for critical care environments, the Proxima System incorporates a dedicated bedside monitor and the Proxima Sensor integrated into a patient’s arterial line. This enables blood to be measured directly at point-of-care without need to leave the patient or manipulate samples and cartridges, which can add to the workload of frontline care staff. Measured to laboratory analyzer accuracy, results are rapidly displayed on the bedside monitor and can be electronically transferred for permanent record.

Simple to use, Proxima enables closed blood sampling and is operated via the touch screen interface of its bedside monitor. When a blood gas analysis is required, blood is withdrawn from the patient directly into the Proxima Sensor without need to open the line, take a sample, and walk away for analysis. Once analysis is completed, all blood is returned to the patient, thereby ensuring blood conservation and reducing the possibility of hospital acquired anemia and subsequent transfusions. A Proxima Sensor is a disposable transducer which can be used for monitoring blood gases and electrolytes over a 72 hour period as many times as required. The system also carries out all quality control checks that would be undertaken on a traditional blood gas analyzer to ensure validity of test results. It also includes a facility to be challenged with liquid controls.

Dr. Tom Clutton-Brock, University Hospital Birmingham, said, “Rapid return of data and swift response to changing blood gases is as essential in patient care as the continual measurement of blood pressure. Fast feedback and response could have a real impact on efficiently stabilizing patients or weaning them from mechanical ventilation.” “Frequent measurement of arterial blood samples is a key component in the effective management of patients in the critical care environment, particularly those that are unstable,” said Dr. Wolfgang Rencken, CEO of Sphere Medical, “we have developed and launched Proxima to keep the caregiver by the patient, conserve blood, and rapidly return blood gas results to aid early decision making and closer control of therapy for critically ill patients—all of which will ultimately improve patient outcomes.”

Also at AAGBI 2014, Sphere Medical sponsored an industry seminar where Dr. Clutton-Brock presented on “True Point-of-Care Testing,” discussing challenges of maintaining control of patient physiology in the ITU, focusing on the frequency of arterial blood sample testing ideally required, and associated limitations such as staff time involved, costs, and blood conservation. He also considered how matters might change if these limitations were removed.

Related Links:
Sphere Medical

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Molecular Diagnostics

view channel
Image: The BIOFIRE® SPOTFIRE® R/ST Panel has received dual 510(k) clearance and CLIA-waiver approval (Photo courtesy of bioMérieux)

Respiratory and Throat Infection PCR Test Detects Multiple Pathogens with Overlapping Symptoms

The COVID-19 pandemic has demonstrated the need for healthcare professionals to have diagnostic tests available as close as possible to the patient, providing actionable results quickly.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.